Full Paper
Self-assembly of Cytotoxic Peptide Amphiphiles into Supramolecular Membranes for Cancer Therapy
Article first published online: 31 JUL 2012
DOI: 10.1002/adhm.201200118
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Issue

Advanced Healthcare Materials
Special Issue: Future of Nano- and Microscale Materials for Healthcare
Volume 2, Issue 1, pages 126–133, January, 2013
Additional Information
How to Cite
Zha, R. H., Sur, S. and Stupp, S. I. (2013), Self-assembly of Cytotoxic Peptide Amphiphiles into Supramolecular Membranes for Cancer Therapy. Advanced Healthcare Materials, 2: 126–133. doi: 10.1002/adhm.201200118
Publication History
- Issue published online: 8 JAN 2013
- Article first published online: 31 JUL 2012
- Manuscript Received: 11 APR 2012
Correction: Correction: Self-assembly of Cytotoxic Peptide Amphiphiles into Supramolecular Membranes for Cancer Therapy
Vol. 2, Issue 5, 631, Article first published online: 2 MAY 2013
Keywords:
- breast cancer;
- drug delivery;
- membranes;
- peptide amphiphiles;
- self-assembly
Abstract
Peptide amphiphiles (PAs) provide a versatile platform for the design of complex and functional material constructs for biomedical applications. The hierarchical self-assembly of PAs with biopolymers is used to create robust hybrid membranes with molecular order on the micron scale. Fabrication of membranes by assembling hyaluronic acid with positively charged PA nanostructures containing anti-cancer PAs bearing a (KLAKLAK)2 peptide sequence is reported here. Changes in membrane microstructure as the positively charged PA nanostructures vary from cylindrical nanofibers to spherical aggregates are characterized. Results indicate that formation of highly aligned fibrous membranes requires a threshold concentration of nanofibers in solution. Additionally, variation of PA nanostructure morphology from spherical aggregates to cylindrical nanofibers allows membranes to act either as reservoirs for sustained release of cytotoxicity upon enzymatic degradation or as membranes with surface-bound cytotoxicity, respectively. Thus, the self-assembly processes of these PA-biopolymer membranes can be potentially used to design delivery platforms for anti-cancer therapeutics.

2192-2659/asset/olbannercenter.jpg?v=1&s=5e7ba40c3a8dfc3e68bdc91c837248e56c9c2167)